ClinicalTrials.gg
Not yet recruitingNCT07897045Updated Oct 27, 2026

Dural Puncture Epidural With 27G vs 26G Needles Versus Standard Epidural for Elective Cesarean Delivery

An interventional study of Standard Epidural Anesthesia and Dural Puncture Epidural With 27G Spinal Needle in Cesarean Section, Anesthesia, Obstetrical and Anesthesia, Epidural, sponsored by Ankara City Hospital Bilkent. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Treatment

Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
165
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to learn whether the dural puncture epidural (DPE) technique shortens the onset time of surgical anesthesia compared with the standard epidural technique in healthy women undergoing elective cesarean delivery, and whether the size of the spinal needle used for dural puncture (27-gauge vs 26-gauge pencil point) changes this effect.

The main question it aims to answer is: Does DPE with a 27G or 26G spinal needle reduce the time from completion of epidural drug injection to bilateral T5 sensory block compared with standard epidural anesthesia?

Researchers will also compare hypotension, ephedrine use, need for additional epidural local anesthetic, motor block, sensory block regression, and post-dural puncture headache among the three groups.

Participants will be randomly assigned to one of three groups: standard epidural, DPE with a 27G spinal needle, or DPE with a 26G spinal needle. In all groups, the same epidural drug mixture will be given through the epidural catheter, and no drug will be injected into the cerebrospinal fluid. Sensory block will be tested every minute after injection, and headache will be checked at 24 and 48 hours after surgery.

02

Conditions studied

  • Cesarean Section
  • Anesthesia, Obstetrical
  • Anesthesia, Epidural

Keywords

  • dural puncture epidural
  • epidural anesthesia
  • elective cesarean delivery
  • spinal needle gauge
  • post-dural puncture headache
  • onset time
03

In context

Post-Dural Puncture Headache

129 studies on the registry are indexed under Post-Dural Puncture Headache; 26 are open to participants now.

This study's planned enrollment of 165 is above the median of 80 across 85 interventional studies indexed under Post-Dural Puncture Headache.

Browse Post-Dural Puncture Headache studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 439 studies on the registry; 110 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women scheduled for elective cesarean delivery under epidural anesthesia
  • American Society of Anesthesiologists (ASA) physical status II
  • No comorbid disease
  • Age 18-40 years
  • Body mass index \<35 kg/m²
  • Term pregnancy (≥37 weeks of gestation)
  • Written informed consent

Exclusion criteria

Exclusion Criteria:

  • Contraindications to neuraxial anesthesia (e.g., coagulopathy, local infection at the puncture site)
  • Emergency cesarean delivery
  • Refusal to participate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
165 participants (estimated)

Study arms

  • Active comparator
    Standard Epidural (EA)

    Epidural space identified at L3-4 or L4-5 with an 18G epidural needle; catheter advanced 3-4 cm; test dose 2 mL 2% lidocaine, then 7.5 mL 1% prilocaine + 7.5 mL 0.5% bupivacaine + 100 mcg fentanyl in 5 mL increments every 3 minutes.

    Procedure: Standard Epidural Anesthesia

  • Experimental
    DPE 27G

    Same as EA, but after epidural space identification the dura is punctured with a 27G spinal needle through the 18G epidural needle; CSF return is confirmed and no intrathecal drug is given before catheter placement. Same epidural drug regimen.

    Procedure: Dural Puncture Epidural With 27G Spinal Needle

  • Experimental
    DPE 26G

    Same as DPE 27G, using a 26G spinal needle for dural puncture. Same epidural drug regimen.

    Procedure: Dural Puncture Epidural With 26G Spinal Needle

Interventions

  • ProcedureStandard Epidural Anesthesia

    Epidural catheter placed with an 18G epidural needle without dural puncture; anesthesia established with the study epidural drug mixture.

    Also known as: EA; conventional epidural

  • ProcedureDural Puncture Epidural With 27G Spinal Needle

    Needle-through-needle dural puncture with a 27G spinal needle via an 18G epidural needle, followed by epidural catheter placement without intrathecal drug; anesthesia established with the study epidural drug mixture.

    Also known as: DPE-27

  • ProcedureDural Puncture Epidural With 26G Spinal Needle

    Needle-through-needle dural puncture with a 26G spinal needle via an 18G epidural needle, followed by epidural catheter placement without intrathecal drug; anesthesia established with the study epidural drug mixture.

    Also known as: DPE-26

06

What researchers measure

Primary outcomes

  1. Onset time of surgical anesthesia

    Time (minutes) from completion of epidural drug injection (t0) to bilateral loss of pinprick sensation at the T5 dermatome, assessed every minute.

    Time frame: From t0 up to 20 minutes

Secondary outcomes

  1. Incidence of hypotension

    Proportion of patients with systolic blood pressure \<90 mmHg or \>20% decrease from baseline.

    Time frame: From t0 to 50 minutes

  2. Intraoperative ephedrine requirement

    Total ephedrine dose (mg).

    Time frame: From t0 to end of surgery (assessed up to 50 minutes)

  3. Need for additional epidural local anesthetic

    Proportion of patients requiring a supplemental epidural dose and total supplemental dose (mg).

    Time frame: From t0 to end of surgery (assessed up to 50 minutes)

  4. Motor block intensity

    Modified Bromage score (0=no motor block, 4=complete blokck of motor limb)

    Time frame: From t0 to 50 minutes

  5. Motor block recovery time

    Time (minutes) from t0 to Bromage score transitions 3→2, 2→1 and 1→0.

    Time frame: Postoperative, up to 24 hours

  6. Sensory block regression time

    Time (minutes) from t0 to two-segment regression and regression of sensory block to T10, L1 and S2.

    Time frame: Postoperative, up to 24 hours

  7. Post-dural puncture headache

    Incidence and severity of postural headache (Visuel analogue score (VAS) 0-10).(VAS=0 no pain, VAS=10 unbearable pain)

    Time frame: 24 and 48 hours after surgery

  8. Blood pressure

    Systolic, diastolic and mean arterial pressure, in mmHg

    Time frame: Every minute for 15 minutes, then every 5 minutes up to 50 minutes

  9. heart rate

    the number of times heart beats per minute , pulse/min

    Time frame: Every minute for 15 minutes, then every 5 minutes up to 50 minutes

  10. SpO2

    the percentage of oxygen-carrying hemoglobin compared to the total hemoglobin in the blood (%)

    Time frame: Every minute for 15 minutes, then every 5 minutes up to 50 minutes

07

Study locations

1 site
  • Ankara City Hospital Bilkent
    Ankara, 06800, Turkey (Türkiye)
    • Havva Esra Uyar Türkyılmaz, MD · Contact · esrauyarturkyilmaz@yahoo.com · 905053840429
    • Nihan Aydın Güzey, MD · Contact · nihanaydinguzey@gamil.com · 905056496231
    • Havva Esra Uyar Türkyılmaz · Principal investigator
    • Nihan Aydın Güzey · Sub investigator
    • İrem Dinçer · Sub investigator
08

References and documents

Publications

  • Sharawi N, Williams M, Athar W, Martinello C, Stoner K, Taylor C, Guo N, Sultan P, Mhyre JM. Effect of Dural-Puncture Epidural vs Standard Epidural for Epidural Extension on Onset Time of Surgical Anesthesia in Elective Cesarean Delivery: A Randomized Clinical Trial. JAMA Netw Open. 2023 Aug 1;6(8):e2326710. doi: 10.1001/jamanetworkopen.2023.26710. PubMed 37526934 ↗
  • Rao WY, Xu F, Dai SB, Mei Z, Chen XP, Lv CC, Liu CL, Ngan Kee W, Chen XZ. Comparison of Dural Puncture Epidural, Epidural and Combined Spinal-Epidural Anesthesia for Cesarean Delivery: A Randomized Controlled Trial. Drug Des Devel Ther. 2023 Jul 18;17:2077-2085. doi: 10.2147/DDDT.S415684. eCollection 2023. PubMed 37484190 ↗
  • Chau A, Bibbo C, Huang CC, Elterman KG, Cappiello EC, Robinson JN, Tsen LC. Dural Puncture Epidural Technique Improves Labor Analgesia Quality With Fewer Side Effects Compared With Epidural and Combined Spinal Epidural Techniques: A Randomized Clinical Trial. Anesth Analg. 2017 Feb;124(2):560-569. doi: 10.1213/ANE.0000000000001798. PubMed 28067707 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.

Of 32 non-industry interventional studies with no phase under Post-Dural Puncture Headache, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 32. This study's planned 5 months is below that.

Counting every sponsor, half of 33 studies reached it within 9 months; a quarter within 4 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 14, 2026
First posted
Oct 27, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Apr 1, 2027
CompletionEst.
May 1, 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07897045
Responsible party
Esra Uyar Türkyılmaz (associate professor MD, Ankara City Hospital Bilkent) — Principal investigator
First posted
Oct 27, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Apr 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Havva Esra Uyar Türkyılmaz, Associate Professor
Contact
esrauyarturkyilmaz@yahoo.com
90 505 384 04 29
Nihan Aydın Güzey, Associate Professor
Contact
nihanaydinguzey@gmail.com
90 505 649 62 31
Havva Esra Uyar Türkyılmaz, Associate Professor
principal investigator · Ankara City Hospital Bilkent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion